No records
|
170 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Alpha-mangostin Reduces Cell Viability in Sorafenib-surviving Cells by Modulating Multiple Drug Transporters in Hepg2 Hepatocellular Carcinoma Cells |
Wangsaputra V.K., Syarinta S., Louisa M. |
Journal of Applied Pharmaceutical Science |
|
Q2 |
|
|
276 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
The potential of gallic acid as a radiosensitizer on human prostate cancer: A systematic review of preclinical studies |
Cahyono A.T., Louisa M., Mayang Permata T.B., Handoko, Nuryadi E., Kodrat H., Wibowo H., Hariandy Hamid A.R.A., Sekarutami S.M., Gondhowiardjo S.A. |
Malaysian Journal of Medicine and Health Sciences |
|
Q4 |
|
|
344 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
The effect of human immunodeficiency virus infection on adverse events during treatment of drug-resistant tuberculosis: A systematic review and meta-analysis |
Lazarus G., Tjoa K., Iskandar A.W.B., Louisa M., Sagwa E.L., Padayatchi N., Soetikno V. |
PLoS ONE |
|
Q1 |
|
|
382 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Role of TGF-?1 in human breast cancer stem cells |
Hariyanto N.I., Purwandhita R.P., Syahrani R.A., Louisa M., Wanandi S.I. |
Journal of the Pakistan Medical Association |
|
Q4 |
|
|
420 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Curcumin Nanoparticle Enhances the Anticancer Effect of Cisplatin by Inhibiting PI3K/AKT and JAK/STAT3 Pathway in Rat Ovarian Carcinoma Induced by DMBA |
Sandhiutami N.M.D., Arozal W., Louisa M., Rahmat D., Wuyung P.E. |
Frontiers in Pharmacology |
6 |
Q1 |
|
|
549 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
The use of Urinary Lipoarabinomannan (LAM) as a Rapid Diagnostic Test for Adult Pulmonary Tuberculosis in HIV-Positive Patients: An Evidence-based Case Report |
Kusumawardani A., Yanfaunnas A.M., Supandi D.P., Inggita R.A.M., Andayani N.G.A.A.P.T., Louisa M., Soetikno V., Burhan E. |
Journal of International Dental and Medical Research |
|
Q3 |
|
|
555 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Efficacy of adjuvant intrastromal and combination of intrastromal and intracameral voriconazole in aspergillus fumigatus-induced moderate fungal keratitis in rabbits |
Sarika D.T., Louisa M., Rozaliyani A., Evelina, Susiyanti M. |
Medical Journal of Indonesia |
|
Q4 |
|
|
573 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
The future potential of Annona muricata L. extract and its bioactive compounds as radiation sensitizing agents: Proposed mechanisms based on a systematic review |
Wijaya D.A., Louisa M., Wibowo H., Taslim A., Permata T.B.M., Handoko, Nuryadi E., Kodrat H., Gondhowiardjo S.A. |
Journal of HerbMed Pharmacology |
|
Q3 |
|
|
591 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Flt3-itd mutation and flt3 ligand plasma level were not associated with one-year survival of Indonesian acute myeloid leukemia patients |
Rinaldi I., Louisa M., Sari R.M., Arwanih E. |
OncoTargets and Therapy |
|
Q2 |
|
|
608 |
41461551400 |
Melva Louisa |
Dr. Melva Louisa, S.Si., M.Biomed. |
Departemen Farmakologi dan Terapeutik |
Ilmu Biomedik (S3) |
Tpmt genetic variability and its association with hematotoxicity in indonesian children with acute lymphoblastic leukemia in maintenance therapy |
Rosdiana D.S., Setiabudy R., Andalusia R., Gatot D., Louisa M., Bardosono S., Instiaty I. |
Pharmacogenomics and Personalized Medicine |
|
Q2 |
|
|